![]() |
市場調查報告書
商品編碼
1559480
全球呼吸監測設備市場:洞察、競爭格局與市場預測:2030年Respiratory Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
在2024年至2030年的預測期內,呼吸監測設備市場規模預計將以 5.73%的年複合成長率擴大。由於呼吸系統疾病患病率上升、與呼吸系統疾病相關的危險因素增加以及老年人口更容易患呼吸系統疾病,預計呼吸監測設備市場在2024年至2030年的預測期內將出現成長。
根據世界衛生組織 (WHO) 2024年的資料,估計2019年全球約有 2.62億人患有氣喘。此外,根據世界衛生組織2022年癌症資料,2020年全球約有221萬肺癌患者。
肺炎病例不斷增加,這是一種影響肺部的急性呼吸道感染,是影響呼吸監測設備市場成長的另一個因素。根據世界衛生組織2021年的資料,肺炎導致全球 5 歲以下兒童死亡人數的14%,2019年有 74萬名兒童死亡。
此外,結核病、肺水腫、氣胸或肺不張、石棉肺等其他呼吸系統疾病的全球爆發進一步促進了對呼吸監測設備的需求,對呼吸監測設備市場產生積極影響。
本報告檢視了全球呼吸監測設備市場,並提供了市場概況,包括磨損趨勢、產品類型、區域趨勢以及參與市場的公司概況。
Respiratory Monitoring Devices Market by Wearability (Wearable and Non-Wearable), Product Type (Spirometers, Pulse Oximeters, Capnographs, Sleep Tech Devices, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of respiratory disorders and its risk factors, the rising geriatric population prone to respiratory ailments, among others across the globe.
The Respiratory Monitoring Devices market is estimated to grow at a CAGR of 5.73% during the forecast period from 2024 to 2030. The Respiratory Monitoring Devices market is poised for substantial growth owing to the increasing prevalence of respiratory disorders, increasing risk factors associated with respiratory disorders, and the rising geriatric population prone to respiratory ailments, among others during the forecast period from 2024 to 2030.
Respiratory Monitoring Devices Market Dynamics:
According to the World Health Organization (WHO) 2024, it was estimated that worldwide around 262 million people were suffering from asthma in 2019. Also, as per the WHO data on cancer 2022, globally around 2.21 million cases of lung cancer were recorded in 2020.
The rising cases of pneumonia, which is a type of acute respiratory infection affecting the lungs is another factor impacting the growth of the respiratory monitoring devices market. As per the WHO 2021, worldwide pneumonia caused 14% of all deaths of children under 5 years old, killing 740,180 children in 2019.
Moreover, the occurrences of other respiratory disorders such as tuberculosis, pulmonary edema, pneumothorax or atelectasis, asbestosis, and others worldwide will further drive the demand for respiratory monitoring devices, positively impacting the respiratory monitoring devices market.
As per the WHO 2021, worldwide around 10 million people were suffering from tuberculosis (TB) with 5.6 million cases in men, 3.3 million cases in women, and 1.1 million cases in children in 2020. This indicated the growing need for monitoring devices so that timely treatment for TB can be provided.
Thus, the interplay of all the above-mentioned factors is expected to boost the market demand for respiratory monitoring devices, and therefore its overall market during the forecast period from 2024 to 2030.
However, the high cost associated with respiratory monitoring devices, and the stringent regulatory approvals for the devices, among others may act as restraining factors for the overall growth of the Respiratory Monitoring Devices during the forecast period.
Respiratory Monitoring Devices Market Segment Analysis:
Respiratory Monitoring Devices Market by Wearability (Wearable and Non-Wearable), Product Type (Spirometers, Pulse Oximeters, Capnographs, Sleep Tech Devices, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the Respiratory Monitoring Devices market, the spirometers category is projected to hold a considerable market share in 2023. This can be attributed to the various features and applications provided by spirometers, along with the product development activities in the spirometers category, during the forecast period.
Spirometers form a valuable tool for studying multiple respiratory problems such as asthma, chronic obstructive pulmonary disease (COPD), and others. They are also used to evaluate possible respiratory disorders and can be used to test lung functioning before surgery.
Spirometers take into account the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled. The commonly taken measurements by spirometers include Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), and FEV1/FVC.
In March 2021, Vyaire Medical announced the launch of the AioCare mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia. This clinically proven technology expanded upon Vyaire's deep respiratory diagnostics expertise allowing physicians to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers. It also performs high-quality patient monitoring via advanced digital connectivity at home.
Hence, owing to all the aforementioned factors, the market will experience an increased demand for spirometers, thus driving the respiratory monitoring devices market during the forecast period.
North America is expected to dominate the overall Respiratory Monitoring Devices market:
North America is expected to account for the highest proportion of the Respiratory Monitoring Devices market in 2023, out of all regions. North America is also expected to dominate the overall Respiratory Monitoring Devices market during the given forecast period from 2024 to 2030.
The major factors driving the market for Respiratory Monitoring Devices in North America are the presence of a large patient pool suffering from respiratory disorders, product approvals, and the presence of a sophisticated healthcare infrastructure in the US, among others across the region during the forecast period.
According to data provided by the Centers for Disease Control and Prevention 2023, it was recorded that 24,963,874 people in the United States were suffering from asthma in the year 2021. The source further stated that 4,675,475 children below the age of 18 years, had reported having asthma in 2021, in the United States. In another set of statistics published by the Centers for Disease Control and Prevention 2023, it was stated that around 14.2 million adults were diagnosed with chronic obstructive pulmonary disorder in the year 2021.
The high patient population base associated with respiratory disorders is expected to propel the demand for respiratory monitoring devices in the US, in the upcoming years.
In 2020, Aluna, a portable spirometry device received clearance from the US Food and Drug Administration, which monitors lung health at home without the need to visit the doctor.
Thus, due to the interplay of all the above-mentioned factors, the market growth for respiratory monitoring devices is expected to surge in the United States during the forecast period from 2024 to 2030.
Respiratory Monitoring Devices Market Key Players:
Some of the key market players operating in the Respiratory Monitoring Devices market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.
Recent Developmental Activities in the Respiratory Monitoring Devices Market:
Key Takeaways from the Respiratory Monitoring Devices Market Report Study:
Target audience who can be benefited from this Respiratory Monitoring Devices Market Report Study:
Frequently Asked Questions for the Respiratory Monitoring Devices Market:
A respiratory monitor is a device that can be used in a hospital or in the home to monitor respiration rate. These devices measure respiratory rate and heart rate, transmitting real-time data displaying and log values for various time points.
The Respiratory Monitoring Devices market is estimated to grow at a CAGR of 5.73% during the forecast period from 2024 to 2030.
The Respiratory Monitoring Devices market is poised for substantial growth, owing to the increasing prevalence of respiratory disorders, increasing risk factors associated with respiratory disorders, and the rising geriatric population prone to respiratory ailments, among others during the forecast period from 2024 to 2030.
Some of the key market players operating in the Respiratory Monitoring Devices market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.
North America is expected to account for the highest proportion of the Respiratory Monitoring Devices market in 2023, out of all regions. The major factors driving the market for Respiratory Monitoring Devices in North America are the presence of a large patient pool suffering from respiratory disorders, product approvals, and the presence of a sophisticated healthcare infrastructure in North America, among others across the region during the forecast period.